Oral Session 1-12B ALL: Basic (2)

[OS1-12B-3] Distinctive drug response profiling of MEF2D-fusion-positive ALL cell lines

Takeshi Inukai¹, Koshi Akahane¹, Keiko Kagami¹, Masako Abe¹, Daisuke Harama¹, Atsushi Watanabe¹, Kumiko Goi¹, Hiroaki Goto², Shotaro Iwamoto³, Masayoshi Minegishi⁴, Takahiko Yasuda⁵, Shinobu Tsuzuki⁶, Fumihiko Hayakawa⁷, Kanji Sugita¹ (1.Pediatrics, University of Yamanashi, Chuo, Japan, 2.Hematology/Oncology, Kanagawa Children's Medical Center, Kanagawa, Japan, 3.Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan, 4.Japanese Red Cross Miyagi Blood Center, Sendai, Japan, 5.Clinical Research Center, Nagoya Medical Center, Nagoya, Japan, 6.Biochemistry, Aichi Medical University, Nagakute, Japan, 7.Pathophysiological Laboratory Sciences, Nagoya University, Nagoya, Japan)